---
figid: PMC9495514__antioxidants-11-01705-g002
pmcid: PMC9495514
image_filename: antioxidants-11-01705-g002.jpg
figure_link: /pmc/articles/PMC9495514/figure/antioxidants-11-01705-f002/
number: Figure 2
figure_title: ''
caption: 'ICS II improved lipid profiles in the serum and hepatic steatosis of db/db
  mice. (a) H&E staining (×200, scale bar = 100 μm) and Oil red O staining (×400,
  scale bar = 50 μm). (b) Quantitation of Oil red O staining. The area of positive
  staining per field were calculated using ImageJ. (c) TC level (n = 8). (d) TG level
  (n = 8). (e) LDL level (n = 8). (f) ALT level (n = 8). (g) AST level (n = 8). Data
  were presented as mean ± SEM. ** p < 0.01 versus WT group; #p < 0.05, ##p < 0.01
  versus db/db group.'
article_title: 'Icariside II Exerts Anti-Type 2 Diabetic Effect by Targeting PPARα/γ:
  Involvement of ROS/NF-κB/IRS1 Signaling Pathway.'
citation: Yiqi Li, et al. Antioxidants (Basel). 2022 Sep;11(9):1705.
year: '2022'

doi: 10.3390/antiox11091705
journal_title: Antioxidants
journal_nlm_ta: Antioxidants (Basel)
publisher_name: MDPI

keywords:
- Icariside II
- Type 2 diabetes mellitus
- peroxisome proliferator-activated receptors α and γ
- oxidative stress
- inflammation

---
